GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 82 filers reported holding GALENA BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $30,000 | -6.2% | 20,407 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $32,000 | -8.6% | 20,407 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $35,000 | +105.9% | 20,407 | +66.0% | 0.00% | +100.0% |
| Q1 2015 | $17,000 | -10.5% | 12,297 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $19,000 | -24.0% | 12,297 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $25,000 | – | 12,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EQUITEC SPECIALISTS, LLC | 368,500 | $129,000 | 0.04% |
| Point72 Hong Kong Ltd | 50,300 | $18,000 | 0.01% |
| Mirador Capital Partners LP | 29,195 | $10,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 77,568 | $27,000 | 0.01% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 39,000 | $14,000 | 0.01% |
| EQUITEC SPECIALISTS, LLC | 45,600 | $16,000 | 0.01% |
| Alyeska Investment Group, L.P. | 1,593,277 | $559,000 | 0.01% |
| Aspen Investment Management Inc | 15,000 | $5,000 | 0.00% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 25,000 | $10,000 | 0.00% |
| ACG Wealth | 25,000 | $9,000 | 0.00% |